447 related articles for article (PubMed ID: 25504627)
21. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA Expression Signature Is Altered in the Cardiac Remodeling Induced by High Fat Diets.
Guedes EC; França GS; Lino CA; Koyama FC; Moreira Ldo N; Alexandre JG; Barreto-Chaves ML; Galante PA; Diniz GP
J Cell Physiol; 2016 Aug; 231(8):1771-83. PubMed ID: 26638879
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
Hirt MN; Werner T; Indenbirken D; Alawi M; Demin P; Kunze AC; Stenzig J; Starbatty J; Hansen A; Fiedler J; Thum T; Eschenhagen T
J Mol Cell Cardiol; 2015 Apr; 81():1-9. PubMed ID: 25633833
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4.
Xiao Y; Zhang X; Fan S; Cui G; Shen Z
PLoS One; 2016; 11(12):e0168078. PubMed ID: 27992564
[TBL] [Abstract][Full Text] [Related]
25. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
Xu X; Wang J; Wang X
Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3β.
Yu YH; Zhang YH; Ding YQ; Bi XY; Yuan J; Zhou H; Wang PX; Zhang LL; Ye JT
Acta Pharmacol Sin; 2021 May; 42(5):715-725. PubMed ID: 32814818
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
28. [Overexpression of miR-130a-3p attenuates cardiomyocyte hypertrophy].
Wang X; Qu J; Li D; Li J; Wu W; Liu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Apr; 37(2):340-348. PubMed ID: 32329288
[TBL] [Abstract][Full Text] [Related]
29. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
Shi JY; Chen C; Xu X; Lu Q
Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
[TBL] [Abstract][Full Text] [Related]
30. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.
Ge Y; Pan S; Guan D; Yin H; Fan Y; Liu J; Zhang S; Zhang H; Feng L; Wang Y; Xu R; Yin JQ
Biochim Biophys Acta; 2013 Jan; 1832(1):1-10. PubMed ID: 23000971
[TBL] [Abstract][Full Text] [Related]
33. LncRNA TINCR improves cardiac hypertrophy by regulating the miR-211-3p-VEGFB-SDF-1α-CXCR4 pathway.
Tu S; Wang XY; Zeng LX; Shen ZJ; Zhang ZH
Lab Invest; 2022 Mar; 102(3):253-262. PubMed ID: 34732848
[TBL] [Abstract][Full Text] [Related]
34. Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779.
Lin H; Zhu Y; Zheng C; Hu D; Ma S; Chen L; Wang Q; Chen Z; Xie J; Yan Y; Huang X; Liao W; Kitakaze M; Bin J; Liao Y
Circulation; 2021 Jun; 143(23):2277-2292. PubMed ID: 33757294
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
36. STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis.
Zhang J; Liang Y; Huang X; Guo X; Liu Y; Zhong J; Yuan J
Sci Rep; 2019 Jan; 9(1):460. PubMed ID: 30679521
[TBL] [Abstract][Full Text] [Related]
37. HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.
Renaud L; Harris LG; Mani SK; Kasiganesan H; Chou JC; Baicu CF; Van Laer A; Akerman AW; Stroud RE; Jones JA; Zile MR; Menick DR
Circ Heart Fail; 2015 Nov; 8(6):1094-104. PubMed ID: 26371176
[TBL] [Abstract][Full Text] [Related]
38. Shenfu Injection attenuates rat myocardial hypertrophy by up-regulating miR-19a-3p expression.
Mao ZJ; Zhang QL; Shang J; Gao T; Yuan WJ; Qin LP
Sci Rep; 2018 Mar; 8(1):4660. PubMed ID: 29549288
[TBL] [Abstract][Full Text] [Related]
39. LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.
Zou X; Wang J; Tang L; Wen Q
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):482-490. PubMed ID: 31183682
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
